CIK 0001935979 · Large accelerated filer
Biohaven Ltd.
Sign in to watch- Ticker
- BHVN
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Virgin Islands, British
- Entity type
- operating
- Phone
- 203-404-0410
- Business address
- 215 CHURCH STREET, NEW HAVEN, CT, 06510
- Former names
- Biohaven Research Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-05 | Clark George C. VP, Chief Accounting Officer | Grant or award · Restricted Share Unit Award | +10,000 | 10,000 | ||
| 2025-01-05 | Clark George C. VP, Chief Accounting Officer | Option exercise · Restricted Share Unit Award | −2,500 | 7,500 | ||
| 2025-01-05 | Buten Matthew Chief Financial Officer | Option exercise | +4,250 | 196,013 | ||
| 2025-01-05 | Buten Matthew Chief Financial Officer | Shares withheld for taxes | −2,561 | $38.64 | $99K | 193,452 |
| 2025-01-05 | Buten Matthew Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +104,000 | 104,000 | ||
| 2025-01-05 | Buten Matthew Chief Financial Officer | Grant or award · Restricted Share Unit Award | +17,000 | 17,000 | ||
| 2025-01-05 | Buten Matthew Chief Financial Officer | Option exercise · Restricted Share Unit Award | −4,250 | 12,750 | ||
| 2025-01-05 | Coric Vlad Chief Executive Officer | Option exercise | +14,250 | 1,803,409 | ||
| 2025-01-05 | Coric Vlad Chief Executive Officer | Shares withheld for taxes | −6,805 | $38.64 | $263K | 1,796,604 |
| 2025-01-05 | Coric Vlad Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +343,000 | 343,000 | ||
| 2025-01-05 | Coric Vlad Chief Executive Officer | Grant or award · Restricted Share Unit Award | +57,000 | 57,000 | ||
| 2025-01-05 | Coric Vlad Chief Executive Officer | Option exercise · Restricted Share Unit Award | −14,250 | 42,750 | ||
| 2024-12-30 | CHILDS JOHN W Director | Purchase | +29,000 | $35.94 | $1.0M | 2,368,741 |
| 2024-10-02 | CHILDS JOHN W Director | Purchase | +21,052 | $47.50 | $1000K | 21,052 |
| 2024-10-02 | Coric Vlad Chief Executive Officer | Purchase | +21,052 | $47.50 | $1000K | 861,942 |
| 2024-09-24 | Bailey Gregory Director | Purchase | +5,000 | $44.19 | $221K | 1,620,071 |
| 2024-07-18 | CHILDS JOHN W Director | Purchase | +28,400 | $35.67 | $1.0M | 2,339,741 |
| 2024-06-17 | Car Bruce Chief Scientific Officer | Purchase | +30,000 | $33.58 | $1.0M | 30,000 |
| 2024-05-30 | CHILDS JOHN W Director | Purchase | +28,000 | $35.58 | $996K | 2,311,341 |
| 2024-05-13 | Bailey Gregory Director | Purchase | +15,000 | $34.19 | $513K | 1,615,071 |
Page 4 of 18 · 355 trades